Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 17 stocks, with a combined market cap of $2,612.83 billion, total revenue of $615.94 billion and a weighted average PE ratio of 22.48.

Market Cap

2,612.83B

Revenue

615.94B

Profits

116.22B

PE Ratio

22.48

Profit Margin

18.87%

Dividend Yield

2.26%

17 Stocks

No.	Symbol	Company Name	Market Cap	% Change	Volume	Revenue
1	LLY	Eli Lilly and Company	555.99B	-0.50%	291,825	32.07B
2	JNJ	Johnson & Johnson	382.47B	-0.17%	1,163,480	95.33B
3	MRK	Merck & Co., Inc.	262.17B	-0.51%	1,212,055	59.31B
4	ABBV	AbbVie Inc.	256.50B	-0.73%	364,822	55.14B
5	NVS	Novartis AG	202.86B	-1.91%	271,330	52.32B
6	AZN	AstraZeneca PLC	200.96B	-1.57%	663,159	45.00B
7	PFE	Pfizer Inc.	167.25B	0.68%	7,842,197	68.54B
8	AMGN	Amgen Inc.	145.86B	-1.18%	152,375	26.83B
9	SNY	Sanofi	118.61B	-0.83%	203,894	50.70B
10	BMY	Bristol-Myers Squibb Company	101.70B	-0.01%	1,267,463	44.94B
11	GILD	Gilead Sciences, Inc.	97.61B	-0.10%	608,876	27.39B
12	GSK	GSK plc	75.44B	-1.23%	313,161	35.73B
13	BIIB	Biogen Inc.	33.74B	-1.19%	74,089	9.99B
14	GRFS	Grifols, S.A.	8.55B	0.98%	188,450	6.45B
15	OGN	Organon & Co.	2.94B	-2.32%	484,188	6.15B
16	SCLX	Scilex Holding Company	129.43M	-8.46%	285,607	45.20M
17	MIRA	MIRA Pharmaceuticals, Inc.	53.21M	-8.75%	45,364	-